Home >> Research Area >>JAK/STAT Signaling>>JAK>> (3S,4S)-Tofacitinib

(3S,4S)-Tofacitinib

CAS# 1092578-47-6

(3S,4S)-Tofacitinib

Catalog No. BCC4052----Order now to get a substantial discount!

Product Name & Size Price Stock
(3S,4S)-Tofacitinib: 5mg $4025 In Stock
(3S,4S)-Tofacitinib: 10mg Please Inquire In Stock
(3S,4S)-Tofacitinib: 20mg Please Inquire Please Inquire
(3S,4S)-Tofacitinib: 50mg Please Inquire Please Inquire
(3S,4S)-Tofacitinib: 100mg Please Inquire Please Inquire
(3S,4S)-Tofacitinib: 200mg Please Inquire Please Inquire
(3S,4S)-Tofacitinib: 500mg Please Inquire Please Inquire
(3S,4S)-Tofacitinib: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of (3S,4S)-Tofacitinib

Number of papers citing our products

Chemical structure

(3S,4S)-Tofacitinib

3D structure

Chemical Properties of (3S,4S)-Tofacitinib

Cas No. 1092578-47-6 SDF Download SDF
PubChem ID 20111936 Appearance Powder
Formula C16H20N6O M.Wt 312.37
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 100 mg/mL (320.13 mM)
H2O : < 0.1 mg/mL (insoluble)
*"≥" means soluble, but saturation unknown.
Chemical Name 3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
SMILES CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N
Standard InChIKey UJLAWZDWDVHWOW-WCQYABFASA-N
Standard InChI InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of (3S,4S)-Tofacitinib

Description(3S,4S)-Tofacitinib is the S-enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.

(3S,4S)-Tofacitinib Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

(3S,4S)-Tofacitinib Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of (3S,4S)-Tofacitinib

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.2013 mL 16.0067 mL 32.0133 mL 64.0266 mL 80.0333 mL
5 mM 0.6403 mL 3.2013 mL 6.4027 mL 12.8053 mL 16.0067 mL
10 mM 0.3201 mL 1.6007 mL 3.2013 mL 6.4027 mL 8.0033 mL
50 mM 0.064 mL 0.3201 mL 0.6403 mL 1.2805 mL 1.6007 mL
100 mM 0.032 mL 0.1601 mL 0.3201 mL 0.6403 mL 0.8003 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on (3S,4S)-Tofacitinib

Tasocitinib also known as CP690550 is an JAK kinase inhibitor. An IC50 estimated at 0.2 μM for PV patient progenitor cells.

Featured Products
New Products
 

References on (3S,4S)-Tofacitinib

Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-y l)-3-oxopropanenitrile (CP-690,550).[Pubmed:19053756]

J Med Chem. 2008 Dec 25;51(24):8012-8.

Here, we examine the significance that stereochemistry plays within the clinically relevant Janus kinase 3 (Jak3) inhibitor 1 (CP-690,550). A synthesis of all four enantiopure stereoisomers of the drug was carried out and an examination of each compound revealed that only the enantiopure 3R,4R isomer was capable of blocking Stat5 phosphorylation (Jak3 dependent). Each compound was profiled across a panel of over 350 kinases, which revealed a high level of selectivity for the Jak family kinases for these related compounds. Each stereoisomer retained a degree of binding to Jak3 and Jak2 and the 3R,4S and 3S,4R stereoisomers were further revealed to have binding affinity for selected members of the STE7 and STE20 subfamily of kinases. Finally, an appraisal of the minimum energy conformation of each stereoisomer and molecular docking at Jak3 was performed in an effort to better understand each compounds selectivity and potency profiles.

Description

(3S,4S)-Tofacitinib is the less active S-enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.

Keywords:

(3S,4S)-Tofacitinib,1092578-47-6,Natural Products,JAK, buy (3S,4S)-Tofacitinib , (3S,4S)-Tofacitinib supplier , purchase (3S,4S)-Tofacitinib , (3S,4S)-Tofacitinib cost , (3S,4S)-Tofacitinib manufacturer , order (3S,4S)-Tofacitinib , high purity (3S,4S)-Tofacitinib

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: